---
layout: entry
title: "Potential therapeutic agents against COVID-19: What we know so far"
link: "https://doi.org/10.1097/JCMA.0000000000000318"
author:
- Lu, Chih-Chia; Chen, Mei-Yu; Chang, Yuh-Lih

summary:
- "the emerging outbreak of coronavirus disease 2019 (COVID-19) continues to spread all over the world. Agents or vaccines of proven efficacy are in urgent need and are being investigated vigorously worldwide. More clinical trials are being conducted for further confirmation of the effectiveness and safety of these agents in treating COVID. This review summarizes the current evidence of potential therapeutic agents. The emerging outbreak is caused by the severe acute respiratory syndrome."

original:
- "The emerging outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread all over the world. Agents or vaccines of proven efficacy to treat or prevent human coronavirus infection are in urgent need and are being investigated vigorously worldwide. This review summarizes the current evidence of potential therapeutic agents, such as lopinavir/ritonavir, remdesivir, favipiravir, chloroquine, hydroxychloroquine, interferon, ribavirin, tocilizumab and sarilumab. More clinical trials are being conducted for further confirmation of the efficacy and safety of these agents in treating COVID-19."
---

